Literature DB >> 6797510

Adult acute leukaemia: prospects for cure.

J M Goldman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6797510      PMCID： PMC1507396          DOI： 10.1136/bmj.283.6301.1205

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  13 in total

1.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

Authors:  E D Thomas; C D Buckner; R A Clift; A Fefer; F L Johnson; P E Neiman; G E Sale; J E Sanders; J W Singer; H Shulman; R Storb; P L Weiden
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

2.  Bone-marrow transplantation for acute leukemia.

Authors:  K G Blume; W E Spruce; S J Forman; J L Wolf; M J Farbstein; E P Scott; J L Fahey
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

3.  Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

Authors:  P L Weiden; K M Sullivan; N Flournoy; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1981-06-18       Impact factor: 91.245

4.  Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT.

Authors:  H Rodt; H J Kolb; B Netzel; R J Haas; K Wilms; C B Götze; H Link; S Thierfelder
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

5.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Authors:  P L Weiden; N Flournoy; E D Thomas; R Prentice; A Fefer; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

6.  Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens.

Authors:  H D Preisler; Y Rustum; E S Henderson; S Bjornsson; P J Creaven; D J Higby; A Freeman; S Gailani; C Naeher
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

7.  Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression.

Authors:  K M Sullivan; H M Shulman; R Storb; P L Weiden; R P Witherspoon; G B McDonald; M M Schubert; K Atkinson; E D Thomas
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

8.  Cyclosporin A for the treatment of graft-versus-host disease in man.

Authors:  R L Powles; A J Barrett; H Clink; H E Kay; J Sloane; T J McElwain
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

9.  The place of bone-marrow transplantation in acute myelogenous leukaemia.

Authors:  R L Powles; G Morgenstern; H M Clink; D Hedley; G Bandini; H Lumley; J G Watson; D Lawson; D Spence; A Barrett; B Jameson; S Lawler; H E Kay; T J McElwain
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

10.  Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.

Authors:  J K Rees; R M Sandler; J Challener; F G Hayhoe
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.